Drug Delivery Markets, Vol III: Pulmonary Delivery Systems

Table of Contents

Chapter one: Executive Summary

• Market Drivers
• Market Size and Growth
• The Total Pulmonary Drug Delivery Market
• The Total Pulmonary Drug Delivery Only Market
• Competitor and Market Analysis

Chapter two: Introduction and Overview

• Scope and Methodology
• Reasons for pulmonary Drug Delivery Systems
• History and Mechanics of Pulmonary Drug Delivery
• Phases of Drug Action
• Pharmacokinetics of Inhalation
• Inhalation Delivery Technologies
• Metered Dose Inhalers
• Dry Powder Formulations
• Nebulizer Delivery Formulations
• Liquid Formulations
• Nanospheres
• Intranasal Delivery Technologies

Chapter three: Trends and Demographics

• Asthma
• Opportunities for Drug Delivery System Success
• Exubera Breakthrough
• Nano and Microparticulate Systems
• Trends in Liquid Aerosols
• CFC Phase Out
• Expansion of Biotechnology
• Macromolecule Delivery

Chapter four: New Developments

• Prodrug Drug Delivery
• Electrohydrodynamic Aerosol Delivery
• Oxygen Delivery
• Crystallization Technology

Chapter five: Market Size and Growth

• The Total Pulmonary Drug Delivery Market
• Pulmonary Delivery Technology Only Market

Chapter six: Competitive and Market Analysis

• Competitor Analysis
• Market Analysis

Chapter seven: Company Profiles

• 3M Pharmaceuticals
• Alkermes, Inc.
• Aradigm Corporation
• Elan Corporation, Plc
• Innovata BioMed Plc
• MicroDose Technology, Inc
• Nastech Pharmaceutical Company Inc.
• Nektar Therapeutics
• Oriel Therapeutics
• Pipex Pharmaceuticals
• Resiprics, Inc.
• SkyePharma Plc
• Vectura Ltd.
• Ventaira Pharmaceuticals, Inc.

Chapter eight: Companies in Brief

• Bespak
• Direct Haler A/S
• IntraNasal Therapeutics

Appendix: Company Directory

TAble of exhibits

Chapter one: Executive Summary

• Table 1-1: The Worldwide Market for Pulmonary Drug Delivery Technology and Pharmaceuticals 2002-2010
• Figure 1-1: The Worldwide Market for Pulmonary Drug Delivery Technology and Pharmaceuticals 2002-2010
• Table 1-2: The Worldwide Market for Pulmonary Drug Delivery Systems by Pharmaceutical and Drug Delivery Component 2002-2010
• Figure 1-2: The Worldwide Market for Pulmonary Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2002-2010

Chapter two: Introduction and Overview

• Table 2-1: Sequence of Drug Action

Chapter three: Trends and Demographics

• Table 3-1: Worldwide Prevalence of Asthma 2006
• Figure 3-1: Worldwide Prevalence of Asthma 2006
• Table 3-2: World Population by Age Group 2002-2010
• Figure 3-2: World Population by Age Group 2002-2010

Chapter fivE: Market Size and Growth

• Table 5-1: The Worldwide Market for Pulmonary Drug Delivery Technology and Pharmaceuticals 2002-2010
• Figure 5-1: The Worldwide Market for Pulmonary Drug Delivery Technology and Pharmaceuticals 2002-2010
• Table 5-2: The Worldwide Market for Pharmaceuticals Utilizing Pulmonary Drug Delivery Systems by Type 2002-2010
• Figure 5-2: The Worldwide Market for Pharmaceuticals Utilizing Pulmonary Drug Delivery Systems Revenues by Type 2002-2010
• Table 5-3: The Worldwide Market for Pharmaceuticals Utilizing Pulmonary Drug Delivery Technologies Market Share by Type 2002-2010
• Figure 5-3: The Worldwide Market for Pharmaceuticals Utilizing Pulmonary Drug Delivery Technologies by Type 2006
• Figure 5-4: The Worldwide Market for Pharmaceuticals Utilizing Pulmonary Drug Delivery Technologies by Type 2010
• Table 5-4: The Worldwide Market for Pulmonary Drug Delivery Systems by Pharmaceutical and Drug Delivery Component 2002-2010
• Table 5-5 of Revenue by Pharmaceutical and Drug Delivery Component 2002-2010
• Figure 5-5 of Revenue by Pharmaceutical and Drug Delivery Component 2002-2010
• Figure 5-6: The Worldwide Market for Pulmonary Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2006
• Figure 5-7: The Worldwide Market for Pulmonary Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2010

Chapter six: Competitive and Market Analysis

• Table 6-1: Selected Leading and Emerging Suppliers of Pulmonary Drug
• Delivery Technology